Zacks Investment Research on MSN1d
Here's Why You Should Retain OPKO Health Stock in Your Portfolio
OPKO Health, Inc. OPK is well-poised for growth in the coming quarters, courtesy of its potential in RAYALDEE. The optimism ...
Standard-Journal1d
Cencora Announces Date and Time for Second Quarter Fiscal 2025 Earnings Release
Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Second Quarter of Fiscal 2025 on Wednesday, May 7, 2025, prior to the opening of trading on the New York Stock ...
Zacks Investment Research on MSN2d
CAH Stock Rises More Than 13% YTD: Should You Buy, Hold or Sell?
Cardinal Health's CAH pharmaceutical segment has consistently demonstrated resilience and growth, driven by strong demand ...